Optimal treatment allocation and study duration for trials with discrete-time survival endpoints
From MaRDI portal
Publication:1937208
DOI10.1016/j.jspi.2012.11.006zbMath1257.62105MaRDI QIDQ1937208
Mirjam Moerbeek, Katarzyna Jóźwiak
Publication date: 28 February 2013
Published in: Journal of Statistical Planning and Inference (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1016/j.jspi.2012.11.006
survival analysis; cost function; optimal designs; discrete-time longitudinal data; allocation ratio
62P10: Applications of statistics to biology and medical sciences; meta analysis
62K05: Optimal statistical designs
62J12: Generalized linear models (logistic models)
Related Items
Cites Work
- Cost-effective designs for trials with discrete-time survival endpoints
- Maximind-optimal designs for binary longitudinal responses
- Efficiency of Balanced Treatment Allocation for Survival Analysis
- An Introduction to Optimal Designs for Social and Biomedical Research
- Sample Sizes for Clinical Trials
- Evaluation of Sample Size and Power for Analyses of Survival with Allowance for Nonuniform Patient Entry, Losses to Follow-Up, Noncompliance, and Stratification
- On Robust and Efficient Designs for Risk Estimation in Epidemiological Studies
- Sample Size Calculations in Clinical Research
- Survival Analysis
- Unnamed Item
- Unnamed Item
- Unnamed Item
- Unnamed Item
- Unnamed Item